Gain insights from Arcos Dorados' Q1 2025 earnings call as management tackles margin pressures, currency headwinds, and digital growth.

Derived from a DCF model and backed by a relative valuation, my Fair Value estimate is $193.4, about 23% potential upside ...

Discover Compass Pathways' journey in developing COMP360 psilocybin for treatment-resistant depression, tackling regulatory ...

Ideaya Biosciences, Inc. progresses trials for uveal melanoma and solid tumors, with key upcoming data milestones. Click for ...

Gold futures fell to the lowest in more than a month Wednesday as tensions eased in global trade, pushing investors away from ...

Recursion Pharmaceuticals faces a 57% stock drop amid drug setbacks, rising cash burn, and AI discovery doubts.

Bank7 stock soars 41.2% despite mixed data. Discover how strong asset quality & variable rate loans drive growth amid ...

Slow progress, pipeline uncertainty & lack of catalysts weigh despite strong cash. Click to read why KYMR stock is a Hold.

OTC Markets' valuation, strong financials, and strategic initiatives make it a compelling buy despite rising expenses and ...

UiPath appears to be struggling with making the Agentic AI potential show up on the balance sheet. Click here to read an analysis of PATH stock now.

Barrick Mining fell following a report that a judge in Mali is expected to order the reopening of the company's ...

Q1 2025 Earnings Conference Call May 14, 2025 10:00 AM ET. Company Participants. Kimberly Stephens - Vice President of Finance Paul Jew ...